Predicting mortality in patients with ST-elevation myocardial infarction treated with primary percutaneous coronary intervention (PAMI risk score)

Srinivas Addala; Cindy L Grines; Simon R Dixon; Gregg W Stone; Judith A Boura; Anthony B Ochoa; Gregory Pellizzon; William W O'Neill; Joel K Kahn

doi:10.1016/j.amjcard.2003.11.036

Predicting mortality in patients with ST-elevation myocardial infarction treated with primary percutaneous coronary intervention (PAMI risk score)

Am J Cardiol. 2004 Mar 1;93(5):629-32. doi: 10.1016/j.amjcard.2003.11.036.

Authors

Srinivas Addala¹, Cindy L Grines, Simon R Dixon, Gregg W Stone, Judith A Boura, Anthony B Ochoa, Gregory Pellizzon, William W O'Neill, Joel K Kahn

Affiliation

¹ William Beaumont Hospital, Royal Oak, Michigan 48073, USA.

PMID: 14996596
DOI: 10.1016/j.amjcard.2003.11.036

Abstract

We performed a pooled analysis of the Primary Angioplasty in Myocardial Infarction (PAMI) trials to examine predictors of death after primary percutaneous coronary intervention. Using these data, we developed a risk score with a range of 0 to 15 points. The PAMI risk score was found to be a strong predictor of late mortality.

MeSH terms

Aged
Aged, 80 and over
Angioplasty, Balloon, Coronary*
Electrocardiography
Female
Hospital Mortality
Humans
Male
Middle Aged
Myocardial Infarction / mortality*
Myocardial Infarction / physiopathology
Myocardial Infarction / therapy*
Predictive Value of Tests
Retrospective Studies
Risk Assessment / methods*
Severity of Illness Index
Survival Rate
Time Factors